about
Identification of targetable FGFR gene fusions in diverse cancers.The protein tyrosine kinase family of the human genomeReactive oxygen species mediate Epstein-Barr virus reactivation by N-methyl-N'-nitro-N-nitrosoguanidineThe Ubiquitin Ligase Itch and Ubiquitination Regulate BFRF1-Mediated Nuclear Envelope Modification for Epstein-Barr Virus Maturation.Epstein-Barr virus (EBV) Rta-mediated EBV and Kaposi's sarcoma-associated herpesvirus lytic reactivations in 293 cells.Marek's disease virus (MDV) encodes an interleukin-8 homolog (vIL-8): characterization of the vIL-8 protein and a vIL-8 deletion mutant MDV.Gene expression and transcription factor profiling reveal inhibition of transcription factor cAMP-response element-binding protein by gamma-herpesvirus replication and transcription activatorSerologic association of human herpesvirus eight with posttransplant Kaposi's sarcoma in Saudi Arabia.Histone demethylase JMJD2A regulates Kaposi's sarcoma-associated herpesvirus replication and is targeted by a viral transcriptional factor.Autoantigenic proteins that bind recombinogenic sequences in Epstein-Barr virus and cellular DNAIdentification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen.The M type K15 protein of Kaposi's sarcoma-associated herpesvirus regulates microRNA expression via its SH2-binding motif to induce cell migration and invasionEBV reactivation as a target of luteolin to repress NPC tumorigenesis.Epstein-Barr virus BALF3 has nuclease activity and mediates mature virion production during the lytic cycle.Kaposi's sarcoma-associated herpesvirus K-bZIP is a coregulator of K-Rta: physical association and promoter-dependent transcriptional repression.The SWI/SNF Chromatin Regulator BRG1 Modulates the Transcriptional Regulatory Activity of the Epstein-Barr Virus DNA Polymerase Processivity Factor BMRF1.Epstein-Barr virus Rta-mediated transactivation of p21 and 14-3-3σ arrests cells at the G1/S transition by reducing cyclin E/CDK2 activity.Kaposi's sarcoma-associated herpesvirus encodes a bZIP protein with homology to BZLF1 of Epstein-Barr virus.Cell cycle regulation by Kaposi's sarcoma-associated herpesvirus K-bZIP: direct interaction with cyclin-CDK2 and induction of G1 growth arrest.The Epstein-Barr virus replication and transcription activator, Rta/BRLF1, induces cellular senescence in epithelial cells.Epstein-Barr Virus Rta-Mediated Accumulation of DNA Methylation Interferes with CTCF Binding in both Host and Viral Genomes.Luteolin inhibits Epstein-Barr virus lytic reactivation by repressing the promoter activities of immediate-early genes.Epstein-Barr virus BRLF1 induces genomic instability and progressive malignancy in nasopharyngeal carcinoma cells.Identification of the bZIP and Rta homologues in the genome of rhesus monkey rhadinovirus.High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia.The transcriptional activator Sp1, a novel autoantigenDihydrofolate reductase from Kaposi's sarcoma-associated herpesvirusEmodin Inhibits EBV Reactivation and Represses NPC TumorigenesisMicroRNA-486-3p functions as a tumor suppressor in oral cancer by targeting DDR1
P50
Q27852147-97A75B5B-1BE1-4696-850D-6B6C4287C4ABQ28140214-FC97D2A1-EAC0-446B-8974-1D8BF10A6A19Q28537881-D9B79587-BFC4-4114-A601-A02F5DAFCCEFQ30817391-5D1514AB-ADAA-4A62-AB2C-E65AD1F88773Q33851707-268D9415-18BF-4B47-8705-2ADE53380DEAQ33851816-FE1E2268-2062-4E95-8D69-8C5BDF3D8320Q34055674-D3260551-052E-491C-AA2F-04C3ADB6678AQ34460156-004A8FD2-C4FD-490A-A319-EBAB052A4A8AQ34742661-C6BA17C4-3AD8-4350-A7AA-E5587220701AQ35739297-C1C36D97-147A-4E42-9007-0266C60E727BQ35881166-882BE515-6869-4A05-AD61-01702E79AD23Q37033356-20FF3FE0-461C-405D-9A52-87F5D8A19BE7Q37109915-1A709FF4-A6C9-403A-B419-CDBD2280BEEAQ37714026-322E98F8-B87B-4E02-8B4E-490209AE47EBQ38359222-42120966-462A-4A87-B5C5-024BD0647C4BQ38715326-AB281F7C-89D1-46FE-B002-7949D68DE0B9Q39473755-9CC04810-304F-4D36-92D8-493E5BD0ED6AQ39551686-9E5CE1E1-AF99-440F-9242-E2DE9FB906E4Q39864214-CF450809-8B56-4ADD-A8CD-5AD741B6B435Q39903181-C981C3F8-F2AD-4405-A17C-00FBE00A20C7Q40207035-A95965D0-4439-42E9-8C51-85E7831E4F71Q40672283-051C7AF7-1307-4E7E-8893-C17BDE5B5270Q43206312-1D8A2353-ED4C-47FB-A490-800EAB218862Q44071433-062FFB89-9438-484A-AEAD-F2798A4333F7Q48023849-73475B3F-BE8B-42F0-9003-9BE88950BBD9Q73414189-4D920867-C72B-45BC-B725-BEADAC000216Q73466439-74387EF4-5A72-446D-80DD-108D290E45A4Q91299005-29765AFF-CCA1-4EDA-909A-7FB8951C54C3Q93112039-29C74182-C111-46D9-888D-F164389DC441
P50
description
researcher
@en
wetenschapper
@nl
name
S F Lin
@en
S F Lin
@nl
type
label
S F Lin
@en
S F Lin
@nl
prefLabel
S F Lin
@en
S F Lin
@nl
P106
P31
P496
0000-0001-8706-2439